Auris Medical Holding Ltd (EARS) stock is flat 0.00% over the past week and gets a Bearish rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.
InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.
The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.
What's Happening With EARS Stock Today?
Auris Medical Holding Ltd (EARS) stock is down -6.03% while the S&P 500 has gained 0.12% as of 10:49 AM on Tuesday, Jun 22. EARS has fallen -$0.22 from the previous closing price of $3.61 on volume of 515,244 shares. Over the past year the S&P 500 is up 35.67% while EARS has gained 260.64%. EARS lost -$1.49 per share in the over the last 12 months.
To see the top 5 stocks in the Biotechnology industry click here.
More About Auris Medical Holding Ltd
Auris Medical Holding Ltd is a clinical-stage biopharmaceutical company. The company develops therapeutics that address important unmet medical needs in neurotology, rhinology, allergy, and CNS disorders. It has two projects in clinical development: Keyzilen for the treatment of acute inner ear tinnitus and Sonsuvi for the treatment of acute inner ear hearing loss. Its other product candidates are AM-125, AM-201, and AM-301.
Click Here to get the full Stock Score Report on Auris Medical Holding Ltd (EARS) Stock.
